Dr. Jiang’s research focuses on the molecular mechanisms of tau pathology in Alzheimer’s disease and related tauopathies, with a particular interest in nucleocytoplasmic transport, nuclear membrane disruption, and RNA epitranscriptomic regulation. Dr. Jiang earned her medical degree from Shandong University, her Ph.D. in Neurobiology from the National Institute of Environmental Health Sciences (NIEHS/NIH), and completed postdoctoral training at Boston University in Dr. Benjamin Wolozin’s lab. She has made significant contributions to understanding tau oligomers’ toxicity, conducted pioneering work on m6A RNA methylation in neurodegeneration, and developed a patient iPSC-derived 3D brain assembloid model of Alzheimer’s disease. Her research is supported by the NIH, and she collaborates actively to advance innovative therapeutic strategies for Alzheimer’s.

To learn more, visit the Jiang Lab website.